1. Introduction {#sec0005}
===============

Physical capability, the ability to carry out everyday activities, can be objectively measured using simple tests such as grip strength (GS), timed chair stands speed (TCSS), usual walking speed (UWS) and standing balance (SB). Low performance on these tests has been associated with higher future mortality in both community-based cohorts and patient populations ([@bib0105]). In particular, the association between low physical capability and higher mortality has been well described in adults over 70 years old ([@bib0005]; [@bib0100]) with results of a meta-analysis suggesting a linear dose-response relationship ([@bib0005]). This has led to measures such as UWS being termed the sixth 'vital sign' of health ([@bib0025]) and there is growing interest in their use as markers of clinical geriatric syndromes, such as sarcopenia and frailty ([@bib0045]).

However, the association between low physical capability and mortality has been less well characterised in adults \<70 years old and only a limited number of new reports have been published ([@bib0015]; [@bib0020], [@bib0060], [@bib0065], [@bib0075]) since a meta-analysis identified this evidence gap ([@bib0005]). These studies, similar to those included in the previous meta-analysis ([@bib0005]), under-represent women ([@bib0020], [@bib0065], [@bib0075]) and often only evaluate associations between mortality and grip strength rather than exploring a range of physical capability measures ([@bib0060], [@bib0065], [@bib0075]). Emerging evidence from these studies suggests that the association is weaker in younger adults ([@bib0005]) and that there may be a threshold effect, with only the very lowest performers experiencing increased risk of mortality ([@bib0015], [@bib0020], [@bib0040], [@bib0065]), rather than the linear dose-response relationship described in older adults. A recent meta-analysis of the short physical performance battery (SPPB), which combines performance on UWS, TCS and SB tests, aimed to address part of this evidence gap and did demonstrate a linear relationship between the SPPB score and mortality in a range of community and patient populations in different geographical areas ([@bib0070]). However, none of the studies included were from the United Kingdom and only 2 included adults with a mean age of \<70 years.

If measures of physical capability are to be used in clinical practice it is important to know whether they predict mortality similarly in populations of different ages. Additionally, younger population groups are likely to have lower levels of co-morbidity than older cohorts, an important potential confounding factor in physical capability-mortality associations. Therefore, establishing whether associations differ depending on the age of participants could help us understand why low physical capability predicts mortality. Does physical capability simply reflect the underlying cumulative disease burden of older adults or is there another explanation for its association with mortality?

We used the infrastructure of the European Prospective Investigation of Cancer (EPIC)-Norfolk study to evaluate associations between a range of physical capability measures and mortality in men and women spanning a wide age range (48--92 years old). We hypothesised that if underlying co-morbidity explained the relationship, the association between low physical capability and higher mortality would be weaker in younger compared to older cohort members and a threshold effect may be evident in younger participants.

2. Materials and methods {#sec0010}
========================

2.1. Study population and data collection {#sec0015}
-----------------------------------------

At baseline (1993--1997) the EPIC-Norfolk study enrolled over 25 000 community-dwelling men and women (40--70 years old) who were registered with participating GP surgeries in and around the city of Norwich (Norfolk, United Kingdom). This study utilises data from 8477 men and women, now aged 48--92 years old, who underwent tests of physical capability (GS, TCSS, UWS and SB) at the study's third health examination (3HC, 2006--2011) and had complete follow-up in terms of vital status until January 31st 2015. Full details of the study design have been reported elsewhere ([@bib0035]) and ethical approval was received from the Norfolk Local Research Ethics Committee and the East Norfolk and Waveney NHS Research Governance Committee.

The 3HC was held at a central research clinic. Maximum grip strength was ascertained using a hand-held Smedley Dynamometer (Scandidact, Kvistgaard, Denmark). Participants performed the test standing with their forearms bent at 90 ° and the strongest force (kilograms, kg) generated after two trials in each hand was used. UWS was measured as participants walked a 4 m course at a comfortable pace, using aids if necessary. UWS was calculated by dividing the distance walked by the average time taken out of two attempts (cm/s). TCSS was measured by asking participants to rise from a chair five times as quickly as possible with their arms folded across their chest and their feet flat on the floor. TCSS was calculated by dividing five by the time taken (stands/minute: 60\*\[5/time, s\]). Standing balance was ascertained by asking participants to stand for 10 s with their feet apart in parallel, semi-tandem and then tandem positions. Reasons for non-participation were recorded, identifying those unable to attempt the tests for health reasons.

During the clinic appointment, weight and height were measured using digital scales (to the nearest 0.1 kg, Tanita) and a stadiometer (to the nearest 0.1 cm, Chasmores, UK). Waist circumference (WC) was also measured using a D-loop non-stretch fibreglass tape (to the nearest 0.1 cm) placed around the narrowest point between the ribs and iliac crest (or the level of the umbilicus). The average of two measurements was used.

Additionally, each participant self-reported their smoking status (current, ex-smoker, never smoker), alcohol intake (units/week), current wealth (more than enough, just enough or not enough money), television (TV) viewing (hours/day) and physical activity (active, moderately active, moderately inactive, inactive) by returning a health and lifestyle questionnaire mailed to them with their 3HC clinic appointment. In particular, physical activity was measured using a four point index derived from activity at work, at home and during leisure time, validated against daily energy expenditure ([@bib0110]). Occupational social class had been ascertained at baseline using a similar questionnaire.

A history of heart attack, stroke, cancer (all cancers except non-melanoma skin cancers) and/or diabetes was established by combining self-report of these conditions at baseline (and during the 2HC, 1998- 2000) with incident data captured over the follow-up period via record linkage with hospital episode statistics (International Classification of Disease \[ICD\] codes: non-fatal MI- ICD9 code 410 and ICD10 codes I21-I22; non-fatal stroke- ICD9 codes 430--438 and ICD10 codes I60-I69; non-fatal cancers- ICD9 codes 140--208 and ICD10 codes C00-C97; diabetes- ICD9 code 250 and ICD10 codes E10-E14). Each co-morbid condition was entered as a separate binary variable in analyses (yes/no).

Participants were followed up from the date of their 3HC clinic appointment until the date of their death or 31st January 2015. The entire cohort has been linked to the NHS Central Register for death and the Office of National Statistics (UK) for death certification since the study's inception ensuring that no participants were lost to follow-up.

2.2. Statistical analyses {#sec0020}
-------------------------

Participant characteristics were described using means, medians and proportions by vital status. Relationships between physical capability and all-cause mortality were explored using Kaplan-Meier curves and Cox proportional hazard regression. For these analyses, sex-specific quartiles (Q) of maximum GS and UWS were generated, with the small number of participants who had been unable to undertake the tests for health reasons added to the lowest performance quartile (GS n = 95; UWS n = 45). TCSS 'quartiles' were also generated. However, those unable to do the TCS test for health reasons (n = 939) were categorised as the lowest performance 'quartile' (Q1) and sex-specific tertiles of TCSS became the upper three 'quartiles'. The range of each sex-specific category of physical capability are described in Table S1 (Supplementary data). SB was dichotomised into those able versus unable to hold a tandem stand for 10s. Although the standing balance test is usually scored from 0 to 4 depending on ability to stand with feet in a side-by-side and semi-tandem, as well as tandem position ([@bib0030]), very few members of our cohort were unable to complete the side-by-side and semi-tandem stands. For all physical capability measures the best performance category was chosen as the reference category, so that hazard ratios (HR) represented the risk of mortality associated with lower physical capability.

No interactions between sex and physical capability were identified (GS: p = 0.71; UWS: p = 0.47; TCSS: p = 0.53; SB: p = 0.10) so both sexes were combined in analyses. To check for violations of the proportional hazards (PH) assumption, Kaplan-Meier plots were inspected for each physical capability measure. Additionally, plots of Schoenfeld's residuals against time were inspected ([@bib0090]). No violations were identified.

To investigate the possibility of different associations with mortality in younger versus older participants, age and sex adjusted hazard ratios for each physical capability measure (Model 1) were calculated for the whole cohort and after stratification into age-groups (\<70 years old versus ≥70 years old). Models with and without an interaction term between age-group and physical capability were compared using likelihood ratio tests.

The potential for co-morbidity or other confounders to explain the relationship between physical capability and mortality was then explored using multivariable models in the whole cohort. First analyses were adjusted for height and weight, in addition to age and sex (Model 2). Then further adjustment for common health risk factors including smoking, alcohol intake, sedentariness (television viewing time), physical activity, occupational social class, and current wealth was made (Model 3) before including the measured co-morbid conditions (Model 4).

Fifteen percent of participants had missing data in at least one co-variable: height (n = 17), waist circumference (n = 19), weight (n = 11), physical activity (n = 120), wealth (n = 483), social class (n = 79), alcohol intake (n = 321) and television viewing (n = 737). Missing data were more likely in those who were female, older, in the lowest physical capability quartile at the 3HC and those who died during the follow-up period (Supplementary data, Table S2). Multiple imputation commands in Stata (version 12.0) were used to impute co-variable data. Imputation models contained all the physical capability measures, all co-variables included in Model 4 and two parameters describing the outcome, namely the variable describing the event (dead) and an estimate of the cumulative hazard from baseline (the Nelson-Aelen estimator). *A priori* imputation models were also stratified by age-group (\<70 years old; ≥70 years old) and sex. Twenty imputed datasets were created and Cox regression analyses were run across each imputed dataset with estimates of the HRs combined using Rubin's rules.

In supplementary work, age and sex adjusted associations were also explored after stratification of the cohort by levels of key potential confounders. For these analyses, grip strength, UWS and TCSS were divided into two categories of good versus poor performance, based on their median cohort values (weak grip strength: \<25 kg \[women\], \<40 kg \[men\]; slow UWS \<110 cm/s; slow TCSS \<25stands/min). Multivariable analyses were also repeated after excluding those who died in the first year of follow-up and after restricting the sample to those with complete co-variable data only.

3. Results {#sec0025}
==========

3.1. Main findings {#sec0030}
------------------

The characteristics of the 8477 participants (55.1% female; mean age 68.7 years \[sd 8.1\]) included in this study are detailed in [Table 1](#tbl0005){ref-type="table"}. Participants were followed up for a median time of 6.0 years (IQR 4.6, 7.5) during which 642 participants died (162 deaths in those \<70 years old and 480 deaths in those ≥70 years old). The crude death rate in men and women respectively was 16.9/1000 person-years (95% CI 15.3, 18.7) and 9.2/1000 person-years (95% CI 8.1, 10.3). Those who died during the follow up period were less likely to consume moderate amounts of alcohol and more likely to be men, older, smokers, have high waist circumference, more co-morbidity, lower physical activity, lower physical capability and to have spent more time watching television at the 3HC than those still alive at the end of the study ([Table 1](#tbl0005){ref-type="table"}).Table 1Characteristics of the 8477 participants with physical capability measurements and complete follow-up.Table 1Co-variable mean (SD)[a](#tblfn0005){ref-type="table-fn"}^,^[b](#tblfn0010){ref-type="table-fn"}Dead (n = 642)Alive (n = 7835)P valueSex, % male (n)59.3 (381)43.7 (3423)\<0.001Age, years75.5 (7.8)68.1 (7.8)\<0.001Height, cm166.3 (9.5)166.3 (9.1)0.94Weight, kg75.3 (15.2)74.4 (14.1)0.10Waist Circumference, cm98.2 (12.7)94.2 (12.2)\<0.001Grip Strength, kg29.3 (9.7)31.1 (10.1)\<0.001Usual Walking Speed, cm/s93.3 (24.7)111.3 (24.7)\<0.001Timed Chair Stands Speed, stands/min23.3 (7.25)26.6 (8.2)\<0.001Standing Balance, % able (n)71.3 (458)88.5 (6933)\<0.001  Co-morbidity, % (n) Yes42.5 (273)15.5 (1215) No57.5 (369)84.5 (6620)\<0.001  Social Class, % (n) Manual31.5 (202)33.9 (2655) Non-manual67.5 (433)65.2 (5108)0.22  Wealth, % (n)Not enough money5.0 (32)6.0 (467)Just enough money63.9 (410)62.6 (4908)More than enough money23.1 (148)25.9 (2029)0.27  Physical Activity, % (n)Inactive54.7 (351)35.1 (2749)Moderately inactive20.1 (129)29.4 (2306)Moderately active14.2 (91)17.9 (1400)Active8.3 (53)16.3 (1278)\<0.001  Daily TV Viewing Time, % (n)≥4 h/day40.5 (260)31.7 (2481)3 \< 4 h/day20.2 (130)22.4 (1757)2 \< 3 h/day13.9 (89)20.9 (1640)\<2 h/day11.8 (76)16.7 (1307)\<0.001  Smoking habit, % (n)Current5.5 (35)4.2 (330)Ex55.1 (354)44.5 (3487)Never36.6 (235)50.0 (3916)\<0.001  Alcohol Intake, median (IQR) None32.9 (211)28.4 (2224) 1--14 units/week50.6 (325)57.1 (4476) \>14 units/week11.2 (72)10.8 (848)0.01[^1][^2][^3]

Participants in lower sex-specific physical capability categories were more likely to die in the follow up period than those in the highest categories, irrespective of the physical capability measure used ([Fig. 1](#fig0005){ref-type="fig"}; also see Supplementary data, Table S3 for crude death rates by physical capability level).Fig. 1Cox Survival Curves (age and sex adjusted).Fig. 1

Associations persisted after stratification of the cohort into younger (\<70 years old) and older (≥70 years old) age groups ([Table 2](#tbl0010){ref-type="table"}). There was no evidence of effect modification by age and associations between physical capability and mortality were similar in the two age-groups studied ([Table 2](#tbl0010){ref-type="table"}).Table 2Associations between objectively measured physical capability and mortality in the EPIC-Norfolk cohort over 6 years of follow-up. Associations are presented for the whole cohort and after division of the cohort into younger (\<70 years) and older (≥70 years) age-groups.Table 2Hazard ratio (95% Confidence Interval)[b](#tblfn0020){ref-type="table-fn"}Whole Cohort\<70years old≥70 years oldPhysical CapabilityNDeathsModel 1NDeathsModel 1NDeathsModel 1P~interaction~[c](#tblfn0025){ref-type="table-fn"}GripQ121362901.97 (1.47, 2.64)693301.87 (1.15, 3.02)14432601.94 (1.28, 2.95)Q220381731.63 (1.22, 2.19)1017451.89 (1.23, 2.91)10211281.57 (1.02, 2.40)Q320851121.33 (0.98, 1.80)1384461.37 (0.90, 2.09)701661.32 (0.84, 2.08)Q42218671.001801411.00417261.000.82  TCSSQ1[a](#tblfn0015){ref-type="table-fn"}9391732.80 (2.11, 3.71)307203.02 (1.77, 5.14)6321532.65 (1.84, 3.81)Q225122191.78 (1.37, 2.32)1093482.21 (1.45, 3.34)14191711.66 (1.17, 2.36)Q325041671.66 (1.27, 2.17)1527501.54 (1.02, 2.31)9771171.72 (1.20, 2.48)Q42522831.001968441.00554391.000.99  UWSQ121523262.67 (1.98, 3.61)691442.91 (1.84, 4.62)14612822.64 (1.73, 4.02)Q220961772.07 (1.52, 2.81)1136522.11 (1.35, 3.28)9601252.09 (1.35, 3.24)Q32103831.19 (0.84, 1.67)1396341.21 (0.75, 1.96)707491.19 (0.73, 1.95)Q42126561.001672321.00454241.000.40  Standing BalanceUnable10861841.52 (1.26, 1.82)288181.83 (1.11, 2.99)7981661.45 (1.18, 1.77)Able73914581.0046071441.0027843141.000.47[^4][^5][^6]

Adjustment for a range of health risk factors did not fully explain the observed associations ([Table 3](#tbl0015){ref-type="table"}) and associations also persisted after further adjustment for the co-morbid conditions considered. Additionally, associations persisted within strata of important confounders, including sex, waist circumference, physical activity, TV viewing time, smoking, alcohol intake and co-morbidity (Supplementary data, Table S4). For example, in those without any history of cancer, stroke, diabetes or myocardial infarction at the 3HC (n = 6989) the risk of mortality was 1.32 (95% CI 1.03, 1.68), 1.77 (95% CI 1.38, 2.27), 1.90 (95% CI 1.48, 2.43) and 1.39 (95% CI 1.08, 1.79) times greater in those with weak GS, slow TCSS, slow UWS and poor SB compared to good performers.Table 3Associations between physical capability and mortality after multivariable adjustment.Table 3Hazard ratio (95% Confidence Interval)[b](#tblfn0035){ref-type="table-fn"}Physical CapabilityNDeathsModel 2 (age, sex, body size)Model 3 (all except co-morbidity)Model 4 (+co-morbidity)GripQ121362902.00 (1.49, 2.70)1.84 (1.36, 2.49)1.80 (1.33, 2.43)Q220381731.65 (1.23, 2.22)1.61 (1.20, 2.17)1.50 (1.12, 2.03)Q320851121.35 (0.99, 1.83)1.30 (0.96, 1.77)1.29 (0.95, 1.75)Q42218671.001.001.00  TCSSQ1[a](#tblfn0030){ref-type="table-fn"}9391732.84 (2.12, 3.78)2.46 (1.83, 3.31)2.29 (1.70, 3.09)Q225122191.81 (1.39, 2.37)1.65 (1.26, 2.16)1.55 (1.18, 2.03)Q325041671.68 (1.29, 2.19)1.59 (1.22, 2.08)1.56 (1.19, 2.04)Q42522831.001.001.00  UWSQ121523262.63 (1.93, 3.56)2.35 (1.72, 3.19)2.16 (1.59, 2.95)Q220961772.05 (1.51, 2.78)1.94 (1.43, 2.64)1.86 (1.36, 2.53)Q32103831.18 (0.84, 1.66)1.17 (0.83, 1.65)1.16 (0.83, 1.63)Q42126561.001.001.00  SBUnable10861841.49 (1.24, 1.79)1.37 (1.14, 1.66)1.33 (1.10, 1.61)Able73914581.001.001.00[^7][^8]

3.2. Sensitivity analyses {#sec0035}
-------------------------

Analyses were conducted after exclusion of participants who died in the first year of follow up (n = 8433, deaths = 598) and after exclusion of participants with incomplete co-variable data (n = 7168, deaths = 504). These did not alter the results (results available on request).

4. Discussion {#sec0040}
=============

Lower physical capability was consistently associated with higher mortality in \>8000 community-based British men and women and a dose-response relationship was evident regardless of age.

Lower physical capability has been robustly associated with higher mortality in people \>70 years old ([@bib0005], [@bib0100]) but few studies have included younger adults and those that have suggest the association might differ. Only those in the lowest quintile of performance (or unable to participate in the tests) were at a higher risk of death in a British cohort of men and women aged 53 years suggesting a threshold effect ([@bib0015]). Additionally, non-linear associations were observed between lower grip strength and higher mortality in Swedish adolescent males ([@bib0065]), with those in the lowest tenth of muscle strength at particularly high risk, and no strong associations between grip strength and mortality were observed in 20--69 year old Canadian men and women ([@bib0040]).

The underlying mechanisms associating lower physical capability with higher mortality are debated. One theory suggests that residual confounding from unmeasured or sub-clinical disease could explain the association. If this were the case, it might be expected that associations would be weaker in younger adults who have a lower co-morbidity burden or only evident in those younger adults most physically unable, who are more likely to have significant illness. However, we observed no evidence of differing associations between physical capability and mortality by age-group and neither adjustment for co-morbidity, exclusion of participants with at least one baseline co-morbid disease nor exclusion of those who died in the first year of follow-up attenuated relationships. Additionally, our results agree with the few other reports that have examined whether age modifies the association between physical capability and mortality. For example, the association between UWS and mortality in British civil servants aged 50--73 years was not modified by age ([@bib0020]) and linear associations between grip strength and mortality were observed across all age-groups within a Japanese cohort aged 35--74 years ([@bib0085]).

We also observed that associations were not substantially attenuated after adjustment for several common health determinants, reducing the likelihood that associations could be explained by risk factors shared between low physical capability and high mortality. In other words, although central obesity, sedentary behaviour, low physical activity and several other health and lifestyle factors included in analyses are associated both with low physical capability ([@bib0010]; [@bib0050]) and higher mortality ([@bib0055], [@bib0115]), they could not fully account for the associations between physical capability and mortality.

If underlying co-morbidity or exposure to shared risk factors cannot fully explain the relationship between physical capability and mortality, it is possible that other biological mechanisms explain the association. Investigators from the Baltimore Longitudinal Study of Ageing suggest that an imbalance of energy availability and energy requirement in later life, leading to an energy deficit, could explain the 'slowing up' associated with age-related organism fragility ([@bib0095]). They hypothesise that when this energy imbalance reaches a critical level, such that basic metabolic functions are threatened, the organism compensates by diverting energy spent on other tasks (e.g., mobility) to support essential metabolic processes. Consistent with this theory, the energy required to walk at the same sub-maximal pace (0.67 m/s) increases with age whilst the total available energy (maximal energy expenditure, VO2~max~ − resting metabolic rate, RMR) declines ([@bib0095]), providing evidence for a less efficient metabolic system in older age. Furthermore, older adults whose RMR does not decline in parallel with the age-related loss of lean mass have higher mortality ([@bib0080]).

There are several limitations to this study. Some important co-morbidities e.g., arthritis, were not included because relevant data had not been collected. Furthermore, it is possible that analyses were underpowered to detect interactions between age and physical capability since there were fewer deaths in younger participants. This also limited the number of sub-groups based on age that could be considered. Therefore, our conclusions must be cautious and the work presented here should be repeated when more follow-up time has elapsed. Additionally, our measure of standing balance was not able to discern significant heterogeneity amongst the cohort because of a 'floor' effect. Most cohort members could fully complete the easier parts of the test and only tandem stands provided evidence of differing balance function.

However, most studies to date have limited power and it is possible that the 'threshold effect' observed in some studies of younger adults is a consequence of relatively few deaths in those above the performance 'threshold' identified. Additionally our work has several strengths. We evaluated several different physical capability tests measured in a large cohort of community-based men and women spanning a wide age-range, including participants younger than 70 years old. We excluded very few participants from analyses since vital status was ascertained for all cohort members, reasons for non-participation in the physical capability tests were recorded and we used multiple imputation to account for missing co-variable data.

5. Conclusion {#sec0045}
=============

In summary, physical capability predicted mortality in late mid-life, when the co-morbidity burden is lower, as well as in old age. Future studies should explore underlying biological pathways linking low physical capability to increased organism fragility.
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Appendix A. Supplementary data {#sec0065}
==============================

The following is Supplementary data to this article:

We would like to thank the participants of the EPIC-Norfolk study and the general practitioners and many administrative and research staff who make the study possible.

Supplementary data associated with this article can be found, in the online version, at <https://doi.org/10.1016/j.archger.2017.10.001>.

[^1]: SD: standard deviation; IQR: inter-quartile range.

[^2]: Unless otherwise indicated.

[^3]: Where applicable percentages may not add up to 100% due to missing data.

[^4]: Those unable to do the test for health reasons.

[^5]: Adjusted for age and sex.

[^6]: P value for age-group\#physical capability interaction term.

[^7]: Those unable to do the test for health reasons.

[^8]: Model 2: adjusted for age, sex, height & weight. Model 3: adjusted for model 2 + social class, wealth, smoking status, alcohol intake, waist circumference (WC), television (TV) viewing time, physical activity, Model 4: adjusted for model 3 + history of cancer (excluding non-melanoma skin cancer), diabetes, stroke and heart attack.
